1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Rallybio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization Anti-(integrin beta-3) human monoclonal antibody - Fetal and Neonatal Alloimmune Thrombocytopenia | Phase 2 | Terminated | Rallybio | 1 | 2024-11-21 | 2026-03-06 |
Thrombocytopenia, Neonatal Alloimmune (1)
Netherlands (1) · Norway (1) · Sweden (1)